Zomedica Pharmaceuticals Corp.

Zomedica Pharmaceuticals Corp. is dedicated to enhancing animal health through innovative diagnostic and therapeutic solutions tailored specifically for veterinary practices. Zomedica Pharmaceuticals Corp. operates in the veterinary health sector, primarily focused on developing diagnostic products.

Established in 2015, the company is headquartered in Ann Arbor, US. The leadership team includes CEOs Jerry Solensky and Larry Heaton, who guide the company in its strategic direction. Zomedica has not undergone any notable pivots or changes in business operations since its inception. Zomedica specializes in advancing animal health through a suite of innovative products tailored for veterinary practitioners.

The company’s core offerings include diagnostic technologies that streamline the diagnostic process from sample collection to result analysis, significantly enhancing the efficiency of veterinary care. Notably, their flagship product, ZOM•Dx, is designed to improve diagnostic accuracy and speed, serving veterinarians in various practice settings. Additionally, Zomedica provides therapeutic solutions such as Assisi’s transcutaneous pulsed electromagnetic field (tPEMF) therapy, which has effectively treated over 50,000 pets, aiding in the reduction of pain, inflammation, and anxiety. Other significant products include VETIGEL, a hemostatic gel that stops bleeding rapidly, and PulseVet shock wave therapy systems, which are extensively used in regenerative veterinary medicine.

Zomedica markets its products primarily in North America, catering to a diverse client base that includes veterinary clinics, hospitals, and animal care facilities. In 2023, Zomedica reported revenue of USD 25. 19 mn, with an EBITDA of USD -27. 50 mn during the same period.

The company generates revenue through direct sales of its proprietary diagnostic and therapeutic products to veterinary practices and clinics, primarily operating on a B2B model. Zomedica's pricing strategy aligns with the veterinary market’s standards, reflecting the value provided through its innovative solutions as it continues to expand its product portfolio.